Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
about
Neuroinflammation and psychiatric illnessTowards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersGlutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatmentStress as a one-armed bandit: Differential effects of stress paradigms on the morphology, neurochemistry and behavior in the rodent amygdala.A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesAstrocyte pathology in major depressive disorder: insights from human postmortem brain tissueThe stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionNeurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidenceTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateBiomarkers of epileptogenesis: psychiatric comorbidities (?)A brief history of the development of antidepressant drugs: from monoamines to glutamateFgfr1 inactivation in the mouse telencephalon results in impaired maturation of interneurons expressing parvalbuminMaternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466GABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseDynamic changes in extracellular release of GABA and glutamate in the lateral septum during social play behavior in juvenile rats: Implications for sex-specific regulation of social play behavior.Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of miceGABA concentration in posterior cingulate cortex predicts putamen response during resting state fMRIRevisiting the monoamine hypothesis of depression: a new perspectiveCommon Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.Sex chromosome complement regulates expression of mood-related genes.GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.Effects of chronic stress on prefrontal cortex transcriptome in mice displaying different genetic backgroundsAdvances in the treatment of anxiety: targeting glutamate.The GABAergic deficit hypothesis of major depressive disorder.gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorderAnxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac.Molecular imaging for depressive disorders.Brain proton magnetic resonance spectroscopy of alcohol use disorders.Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressantsChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.In pursuit of neuroimaging biomarkers to guide treatment selection in major depressive disorder: a review of the literature.A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.Fully automated macromolecule suppressed single voxel glutamate spectroscopy (FAMOUS SVGS).Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS).Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.
P2860
Q21245244-A90DC914-D677-4E30-A127-81D747A83C58Q24632936-BBC0343E-B649-40E3-93D5-3F769A5C6A86Q24633004-EA2A019C-CBB7-4753-A21C-DADC53ADE2FBQ26769043-8AE345E8-C10C-497A-B071-DA1FEA85FF77Q26786354-717454B2-E07F-4034-BDF1-CC8115340649Q26827833-7F6ACDF2-F68E-4619-8CA0-E9040DE8A9AEQ26859198-0AE2FF77-3C61-48A9-8098-9AA2191C4363Q26999061-9B9BA54A-2A10-4FC1-BC38-B272EDF11D5AQ27004490-0859E8C2-B352-44BC-8525-AC67C7220A85Q27015612-A02714F4-8996-4AE9-B2EA-16651B4AFDABQ27028050-E79B13DB-7095-4E5C-B938-3BD56179CC46Q27316919-702F7A27-1DA4-465B-838A-42D4C55C90A6Q27319478-589539C7-D5DC-4C57-92D0-B727C4A02487Q28236198-3CA81040-B776-492A-80EB-485A46E8DE25Q28241963-31125E77-CF47-4D44-9949-AA6E732051C9Q28266736-A55F038A-F405-421D-8967-9AF03DA7C446Q28485938-76B1F87E-3457-4063-9D19-89909762B0CAQ28542754-A6C0C653-0586-4B3D-A95C-816187073BFEQ28660308-989D3516-C36D-426E-B743-92E5F54D784AQ30249189-F5408F4D-80F9-410B-9BCF-FB4B6520DE4EQ30409984-39809A9D-4C2A-46C1-A592-99F1F5547D69Q30421260-DD39A4DB-7774-474D-A94F-CFD81DB3DC44Q30455519-8756842F-1CD3-4092-B36E-E3929B2BB302Q30457479-FF265046-1044-4580-8FD5-A3EAB47D1393Q30464954-9244DBEB-D14B-40AF-A377-C08E0D3A3622Q30496339-03A1BB2C-C2B3-4F5B-9C00-7E95D95B3265Q30572014-9B0B5B89-08A7-4E19-973B-F13715C60018Q30711088-D282D837-F5D3-44B4-89B7-F0828AF77CB1Q30818437-A3E0791B-4832-421C-BB03-BA4E9D1BFB80Q30821361-030764F5-0C06-47C3-87B5-AF0C3634B966Q30859378-DA559A48-876E-40FC-B927-499CB7CA7235Q30887852-A027913F-C5E1-4D9F-852A-C68D9D778C69Q30906677-56997D95-27DB-4925-B6BF-ADF6DFABB8E5Q30927398-60C1554E-9624-4F65-A678-B408FEB44966Q30987882-71F95B57-20CC-4CD0-A5AA-10E65F82A3DDQ31032734-7FF7560D-1458-476D-9CBC-4C89F8375EADQ31090438-ABB55FC7-09E3-4949-AE81-5867E38AB93FQ31117451-AFE4ADE2-70B9-4712-A446-3C60C8C3615AQ33384845-212BE2B8-0240-490B-8FB1-088E9F157FE0Q33389974-9485B5CC-9692-4CFB-BB16-86AFF66E3ADF
P2860
Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Subtype-specific alterations o ...... atients with major depression.
@en
Subtype-specific alterations o ...... atients with major depression.
@nl
type
label
Subtype-specific alterations o ...... atients with major depression.
@en
Subtype-specific alterations o ...... atients with major depression.
@nl
prefLabel
Subtype-specific alterations o ...... atients with major depression.
@en
Subtype-specific alterations o ...... atients with major depression.
@nl
P2093
P1433
P1476
Subtype-specific alterations o ...... atients with major depression.
@en
P2093
C Neill Epperson
Douglas L Rothman
Gerard Sanacora
Graeme F Mason
John H Krystal
Michael Appel
P304
P356
10.1001/ARCHPSYC.61.7.705
P407
P577
2004-07-01T00:00:00Z